<?xml version="1.0" encoding="UTF-8"?>
<div class="supplementary-material" content-type="local-data" id="PMC7496525/supplementary_10" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Supplementary Table 1 Hi‐C datasets used in this study Supplementary Table 2 Tissue‐specific results from CoDeS3D significant (p &lt; 1x10‐6) results from the GBA gene locus Supplementary Table 3 Haploreg v4.1 analysis of rsID, including proteins bound, motifs changed, promoter and enhancer histone marks Supplementary Table 4 Literature review of the eGenes, expression in brain (GTEx V7, 03/03/2019), and their main features as related to PD Supplementary Table 5 Pathway analysis (KEGG), druggability analysis (DGIdb) and protein classification (Protein Atlas) of eGenes Supplementary Table 6 The 55 Haplotype genotypes Supplementary Table 7 Haplotype group designations by patient ID Supplementary Table 8 Haplotype Groups and Phenotype data Supplementary Table 9 Genome‐wide significant (p &lt; 1x10‐6) associations with GBA in substantia nigra and cortex, and associated histone marks and motifs Supplementary Table 10 Genome‐wide significant loci which associate to GBA regulation in substantia nigra and cortex are themselves regulatory of many other genes in a tissue‐specific manner Supplementary Table 11 Alpha‐synuclein aggregates/pathology as observed in five tissues </caption>
 <div class="media" xlink:href="MDS-35-1346-s006.xlsx" xmlns:xlink="http://www.w3.org/1999/xlink">
  <caption> Click here for additional data file. </caption>
 </div>
</div>
